Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.

Moreover, in the AGS cells, average protein levels of survivin were lower at 24h compared to 12h of monastrol treatment, although this difference did not reach statistical significance (Fig 3B and 3C , right panel).

also in 111,027 other papers